Ormat Technologies Overview
Ormat Technologies Target Price
Analysts' 12-month price predictions for ORA.
Get informed when a big investor buys or sells
+ FollowShare Price
$112.56
Average Target Price
$140.33
24.7% upside
24.7% upside6 analysts in the last 4 months
High: $152 | Low: $126
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-18 | Piper Sandler | $142 | 26.2% upside |  |
| 2026-05-11 | Roth Capital | $135 | 19.9% upside | |
| 2026-05-08 | UBSJon Windham | $152 | 35% upside | |
| 2026-05-08 | OppenheimerNoah Kaye | $144 | 27.9% upside | |
| 2026-05-08 | BarclaysDavid Anderson | $126 | 11.9% upside | |
| 2026-03-03 | UBSJon Windham | $143 | 27% upside | |
| 2026-02-13 | Jefferies | $130 | 15.5% upside | |
| 2026-02-04 | UBS | $148 | 31.5% upside | |
| 2026-01-28 | Roth Capital | $139 | 23.5% upside | |
| 2026-01-27 | Oppenheimer | $136 | 20.8% upside | |
| 2026-01-15 | Barclays | $108 |  4.1% downside | |
| 2026-01-14 | Robert W. Baird | $143 | 27% upside | |
| 2025-12-18 | Piper Sandler | $125 | 11.1% upside | |
| 2025-11-24 | JefferiesJulian Dumoulin-Smith | $125 | 11.1% upside | |
| 2025-11-05 | Roth CapitalJustin Clare | $125 | 11.1% upside | |
| 2025-11-05 | OppenheimerNoah Kaye | $125 | 11.1% upside | |
| 2025-10-07 | JefferiesJulien Dumoulin-Smith | $120 | 6.6% upside | |
| 2025-09-17 | Piper Sandler | $102 | 9.4% downside | |
| 2025-08-08 | OppenheimerNoah Kaye | $100 | 11.2% downside | |
| 2025-08-04 | Roth Capital | $98 | 12.9% downside | |
| 2025-03-25 | JefferiesJulien Dumoulin-Smith | $86 | 23.6% downside | |
| 2024-12-18 | Piper SandlerDerek Podhaizer | $78 | 30.7% downside | |
| 2024-06-21 | OppenheimerNoah Kaye | $85 | 24.5% downside | |
| 2024-05-13 | BarclaysDerek Podhaizer | $73 | 35.1% downside | |
| 2022-08-08 | J.P. Morgan | $97 | 13.8% downside | |
| 2022-08-08 | Oppenheimer | $97 | 13.8% downside | |
| 2022-07-20 | J.P. Morgan | $80 | 28.9% downside | |